Q-Pharm, wholly owned by QIMR Berghofer Medical Research Institute, is a state-of-the-art, early-phase clinical trials company providing a broad range of high-quality services to commercial and academic clients around the world.
Since 2002, Q-Pharm has safely and successfully conducted more than 400 early-phase clinical trials in a wide variety of therapeutic areas.
Q-Pharm’s highly qualified teams and leaders have a wealth of experience in clinical development, enabling Q-Pharm to understand the needs of a diverse range of clients, and to meet and exceed their expectations.
Clinical trials conducted at Q-Pharm are accepted by regulators throughout the world, including Australia, Europe, Asia, and the Americas.
Q-Pharm’s speciality clinical trial services include: Comparative PK/PD, SAD/MAD/Food Effect studies, complex First-In-Human studies, vaccines studies, disease challenge models, clinical development strategy and study design consultation.